Glenmede Trust’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$15.5M Sell
704,325
-17,486
-2% -$385K 0.08% 234
2024
Q4
$16.4M Sell
721,811
-5,970
-0.8% -$135K 0.08% 247
2024
Q3
$13.2M Buy
727,781
+405,624
+126% +$7.37M 0.06% 313
2024
Q2
$9.39M Buy
322,157
+2,737
+0.9% +$79.8K 0.05% 358
2024
Q1
$11.3M Buy
319,420
+22,842
+8% +$810K 0.06% 349
2023
Q4
$12.9M Sell
296,578
-9,454
-3% -$412K 0.07% 304
2023
Q3
$11.7M Buy
306,032
+95,857
+46% +$3.66M 0.07% 303
2023
Q2
$11.9M Buy
210,175
+408
+0.2% +$23K 0.07% 307
2023
Q1
$12M Buy
+209,767
New +$12M 0.07% 299
2022
Q2
Sell
-3,292
Closed -$211K 1327
2022
Q1
$211K Sell
3,292
-151
-4% -$9.68K ﹤0.01% 1121
2021
Q4
$230K Sell
3,443
-260
-7% -$17.4K ﹤0.01% 1113
2021
Q3
$253K Sell
3,703
-312
-8% -$21.3K ﹤0.01% 1074
2021
Q2
$273K Buy
4,015
+126
+3% +$8.57K ﹤0.01% 1056
2021
Q1
$268K Sell
3,889
-1,766
-31% -$122K ﹤0.01% 1000
2020
Q4
$367K Sell
5,655
-824
-13% -$53.5K ﹤0.01% 920
2020
Q3
$305K Buy
6,479
+323
+5% +$15.2K ﹤0.01% 915
2020
Q2
$289K Buy
6,156
+1,640
+36% +$77K ﹤0.01% 917
2020
Q1
$263K Hold
4,516
﹤0.01% 1094
2019
Q4
$263K Buy
4,516
+21
+0.5% +$1.22K ﹤0.01% 1094
2019
Q3
$270 Buy
4,495
+89
+2% +$5 ﹤0.01% 1057
2019
Q2
$246 Hold
4,406
﹤0.01% 1093
2019
Q1
$245 Sell
4,406
-3
-0.1% ﹤0.01% 1107
2018
Q4
$198 Sell
4,409
-344,546
-99% -$15.5K ﹤0.01% 1120
2018
Q3
$23M Sell
348,955
-422,924
-55% -$27.9M 0.09% 300
2018
Q2
$49.7M Sell
771,879
-318,954
-29% -$20.5M 0.22% 136
2018
Q1
$52.2M Hold
1,090,833
0.22% 127
2017
Q4
$52.2M Sell
1,090,833
-11,836
-1% -$566K 0.22% 127
2017
Q3
$55.7M Sell
1,102,669
-21,260
-2% -$1.07M 0.24% 116
2017
Q2
$47.3M Hold
1,123,929
0.23% 125
2017
Q1
$47.3M Buy
1,123,929
+1,120,597
+33,631% +$47.1M 0.23% 125
2016
Q4
$142K Buy
3,332
+362
+12% +$15.4K ﹤0.01% 1297
2016
Q3
$122K Buy
+2,970
New +$122K ﹤0.01% 1344